Lonza

One of the leading global suppliers of active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.

Launch date

1897

Employees

10001+ people

Market cap

Enterprise valuation

$4.7b (Public information from Feb 2021)

Company register number OE016646

Basel Canton of Basel-Stadt (HQ)

http://www.lonza.com/

https://twitter.com/lonzagroup https://www.facebook.com/lonzagroupag https://www.linkedin.com/company/lonza

View job openings

Revenues, earnings & profits over time

CHF	2021
Revenues	1.7b

Date	Investors	Amount	Round
-	EDBI	N/A	-
Oct 1999	N/A	N/A	IPO
Jan 2001	Ghent University	N/A	Spinout
Feb 2021*	Bain Capital Cinven	$4.7b Valuation: $4.7b	Acquisition
Nov 2023*	N/A	CHF400m	Post IPO Debt
Jan 2024	SBI Mutual Fund	$163m	Post IPO Equity
Apr 2024*	N/A	€1.0b	Post IPO Debt
Total Funding		-